|
|
| Class Numbers & Titles | Class Numbers Only | USPC Index | International | HELP |
| You are viewing a Class definition. |
CLASS 530, | CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF |
| Click here for a printable version of this file | |
SUBCLASSES
200 | NATURAL RESINS OR DERIVATIVES (E.G., WOOD OR PINE TAR; CATIVO RESIN DERIVATIVES, ETC.): | ||||||||||||||||||||||||||||||||
This subclass is indented under Class 260, subclass
1. Natural resin derivatives which are not pure compounds,
and processes of treating natural resins or derivatives.
SEE OR SEARCH THIS CLASS, SUBCLASS:
SEE OR SEARCH CLASS:
| |||||||||||||||||||||||||||||||||
201 | Shellac containing starting material used in process, or product thereof (e.g., lac, sticklac, seedlac, flake shellac, bleached shellac, etc.): | ||
This subclass is indented under subclass 200. Processes wherein the starting material is shellac, or a
shellac-containing substance, or products of such processes.
| |||
202 | Cut wood starting material used in process, or product thereof (e.g., using pine stumps, chips, bark, etc., as starting material): | ||||||
This subclass is indented under subclass 200. Processes wherein the starting material is cut wood, or
products of such processes.
SEE OR SEARCH THIS CLASS, SUBCLASS:
| |||||||
203 | Plant sap or fossil starting material used in process, or product thereof (e.g., using copal, coal, amber, dammar, etc., as starting material): | ||
This subclass is indented under subclass 200. Processes wherein the starting material is plant sap or
a fossilized substance, or products of such processes.
| |||
204 | Pine oleoresin starting material used in process, or product thereof (e.g., using gum turpentine, pine gum, pine resin, etc., as starting material): | ||||||
This subclass is indented under subclass 203. Processing wherein the starting material is pine oleoresin,
or products of such processes.
| |||||||
205 | Recovery of tall oil or derivatives from papermaking waste, purification of tall oil, or separation of components of tall oil; or product thereof (e.g., separation of rosin, fatty acids, sterols, etc.; decolorizing, etc.): | ||||||||
This subclass is indented under subclass 200. Processes wherein: (1) tall oil or a derivative thereof
is recovered from papermaking waste; (2) one or more components
are separated from tall oil; (3) tall oil is purified; or products
of such processes.
| |||||||||
206 | Organic sulfur or nitrogen containing material used in the process, or product thereof: |
| This subclass is indented under subclass 205. Processes wherein there is utilized an organic material containing sulfur or nitrogen, or products of such processes. | |
207 | Esterification used in the process, or product thereof: |
| This subclass is indented under subclass 205. Processes which include an esterification step, or products of such processes. | |
208 | Inorganic material used in the process, or product thereof (e.g., using sulfuric acid, boric acid, etc.): |
| This subclass is indented under subclass 205. Process wherein there is utilized an inorganic material, or products of such processes. | |
209 | Phosphorus or heavy metal containing material, elemental hydrogen, sulfur dioxide, or carbon dioxide used in the process, or product thereof: |
| This subclass is indented under subclass 208. Processes wherein there is utilized a material containing phosphorus, heavy metal, elemental hydrogen, sulfur dioxide, or carbon dioxide; or products of such processes. | |
210 | Rosin or derivative used as starting material in process, or product thereof (e.g., using gum rosin, wood rosin, solid tall oil rosin, etc.): | ||||||||||||
This subclass is indented under subclass 200. Processes wherein rosin or a derivative thereof is used
as starting material, or products of such processes.
SEE OR SEARCH CLASS:
| |||||||||||||
211 | Polymerization or product thereof (e.g., dimer rosin, etc.): | ||||||||
This subclass is indented under subclass 210. Processes wherein rosin or a derivative thereof is polymerized,
or products of such processes.
SEE OR SEARCH CLASS:
| |||||||||
212 | Chemical treatment or color modification of polymerized rosin or derivative, or product thereof (e.g., hydrogenation or esterification of polymerized rosin; removal of color bodies from polymerized rosin, etc.): |
| This subclass is indented under subclass 211. Processes wherein polymerized rosin or a derivative thereof undergoes further chemical treatment or color modification, or products of such processes. | |
213 | Boron or phosphorus containing material used in the process, or product thereof: |
| This subclass is indented under subclass 210. Processes wherein there is utilized a material containing boron or phosphorus, or products of such processes. | |
214 | Diels-Alder adducts (e.g., of maleic anhydride, fumaric acid, etc., with conjugated dienes, such as rosin acids, terpenes, etc.): | ||||
This subclass is indented under subclass 210. Products which include a six-membered ring formed by the
addition of an alkene or alkyne to the 1,4 - positions of a conjugated
diene.
| |||||
215 | Esterification of rosin or derivative via carboxyl group, or product thereof: | ||
This subclass is indented under subclass 210. Processes wherein the carboxyl group of rosin or of a derivative
thereof is esterified, or products of such processes.
| |||
216 | Chemical treatment or color modification of esterified rosin or derivative, or product thereof (e.g., partial saponification of rosin triglycerides; removal of color bodies from rosin esters, etc.): |
| This subclass is indented under subclass 215. Processes wherein esterified rosin or a derivative thereof undergoes further chemical treatment or color modification, or products of such processes. | |
217 | Oxygen containing ring or halogen containing material used in the esterification, or product thereof (e.g., using alkylene oxides, polysaccharides, alkyl halides, etc.): |
| This subclass is indented under subclass 215. Processes wherein the esterification utilizes an oxygen ring containing compound or a halogen containing material, or products of such processes. | |
218 | Polyhydroxy material used in the esterification, or product thereof (e.g., forming ester gum, etc.): |
| This subclass is indented under subclass 215. Processes wherein the esterification utilizes a polyhydroxy containing material, or products of such processes. | |
219 | Sulfur, selenium, or tellurium containing material used in the process, or product thereof (e.g., disproportionation of rosin, etc.): | ||
This subclass is indented under subclass 210. Processes wherein there is utilized a material containing
sulfur, selenium or tellurium, or products of such processes.
| |||
220 | The sulfur, selenium, or tellurium containing material is inorganic: |
| This subclass is indented under subclass 219. Processes wherein the material containing sulfur, selenium or tellurium is inorganic. | |
221 | Nitrogen containing material used in the process, or product thereof: |
| This subclass is indented under subclass 210. Processes wherein there is utilized a nitrogen containing material, or products of such processes. | |
222 | The nitrogen containing material is inorganic: |
| This subclass is indented under subclass 221. Processes wherein the material containing nitrogen is inorganic. | |
223 | Hydrogenation or product thereof (e.g., forming dihydro rosin acids; rosinyl alcohol or derivatives; etc.): |
| This subclass is indented under subclass 210. Processes wherein rosin or a derivative thereof is reacted with hydrogen, or products of such processes. | |
224 | Metal containing material used to form salts of rosin acids, or product thereof: | ||||||||
This subclass is indented under subclass 210. Processes wherein salts of rosin acids are formed using
a metal containing material, or products of such processes.
SEE OR SEARCH CLASS:
| |||||||||
225 | Alkali metal containing material (i.e., Li, Na, K, Rb or Cs): | ||||
| This subclass is indented under subclass 224. Processes wherein the metal is an alkali metal.
SEE OR SEARCH CLASS:
| |||||
226 | Heat treatment of rosin or derivative in the absence of nonrosin organic reactants, or product thereof (e.g., forming rosin oil; disproportionated, dehydrogenated, or isomerized rosin; etc.): | ||||
This subclass is indented under subclass 210. Processes wherein rosin or a derivative thereof is subjected
to heat treatment in the absence of any additional nonrosin organic
reactant, or products of such processes.
SEE OR SEARCH THIS CLASS, SUBCLASS:
| |||||
227 | Metal, halogen, or silicon containing material used in the process, or product thereof (e.g., using clay, zeolites, etc.): |
| This subclass is indented under subclass 226. Processes wherein a metal, halogen or silicon containing material is utilized, or products of such processes. | |
228 | Purification process or product thereof: |
| This subclass is indented under subclass 210. Processes for purification of rosin or its derivatives, or products of such processes. | |
229 | Immiscible solvents used in the process, or product thereof: |
| This subclass is indented under subclass 228. Processes which utilize immiscible solvents, or products of such processes. | |
230 | Tall oil or derivative used as starting material in process, or product thereof (e.g., metal salts of tall oil fatty acids; tall oil pitch, etc.) dehydrogenated, or isomerized rosin; etc.): | ||||||
This subclass is indented under subclass 200. Processes wherein the starting material used is tall oil
or a derivative thereof, or products of such processes.
| |||||||
231 | Nitrogen containing material used in the process, or product thereof: |
| This subclass is indented under subclass 230. Processes which utilize a nitrogen containing material, or products of such processes. | |
232 | Esterification of tall oil acids, or product thereof: |
| This subclass is indented under subclass 230. Processes wherein the acids present in tall oil are esterified, or products of such processes. | |
233 | Sulfur, boron, phosphorus, or iodine containing material used in the process, or product thereof: |
| This subclass is indented under subclass 230. Processes wherein a material containing sulfur, boron phosphorus, or iodine is utilized, or products of such processes. | |
300 | PEPTIDES OF 3 TO 100 AMINO ACID RESIDUES: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This subclass is indented under Class 260, subclass
1. Compounds consisting of three or more amino acids joined
covalently by peptide bonds.
SEE OR SEARCH CLASS:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
301 | Thymopoietin or Lipotropin; related peptides: | ||||||||||||||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure of Thymopoietin.
SEE OR SEARCH CLASS:
| |||||||||||||||||
302 | Endorphins and Enkephalins; related peptides: | ||||||||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure:
SEE OR SEARCH CLASS:
| |||||||||||
303 | Insulin; related peptides: | ||||||
This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure of insulin.
| |||||||
304 | Metal complexes, e.g., Zn-insulin, etc: | ||||||
This subclass is indented under subclass 303. Peptides in which the peptide is a complex of insulin and
a metal.
| |||||||
305 | Isolation or purification: | ||||
This subclass is indented under subclass 303. Subject matter, in which preexisting insulin is isolated
or separated.
| |||||
306 | Corticotropins (ATCH); related peptides: | ||||||||||
| This subclass is indented under subclass 303. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure:
SEE OR SEARCH CLASS:
| |||||||||||
307 | Calcitonin; related peptides: | ||||||||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure:
SEE OR SEARCH CLASS:
| |||||||||||
308 | Glucagon; related peptides: | ||||||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure.
| |||||||||
309 | Secretin or gastrin; related peptides: | ||||||||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure:
| |||||||||||
310 | Gramicidin or tyrocidin; related peptides: | ||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino residues in
sequence of the polypeptide with the structure:
| |||||
311 | Somatostatin (SRIF); related peptides: | ||||||||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure:
SEE OR SEARCH CLASS:
| |||||||||||
312 | Melanotropin (MSH) or eledoisin; related peptides: | ||||||||||
| Peptides under subclass 300 containing at least half the
amino acid residues in sequence of the polypeptide with the structure:
| |||||||||||
313 | Lutenizing hormone-releasing factor (LRF); related peptides: | ||||||||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure:
SEE OR SEARCH CLASS:
| |||||||||||
314 | Bradykinin; kallidin; related peptides: | ||||||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure:
| |||||||||
315 | Oxytocin; vasopressin; related peptides: | ||||||||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure:
SEE OR SEARCH CLASS:
| |||||||||||
316 | Angiotensin; related peptides: | ||||||||||
| This subclass is indented under subclass 300. Peptides containing at least half the amino acid residues
in sequence of the polypeptide with the structure:
Angiotensin I
Angiotensin II
SEE OR SEARCH CLASS:
| |||||||||||
317 | Cyclic peptides: | ||||||||||
Peptides under subclass 300 containing at least one ring
fused only through peptide bonds.
SEE OR SEARCH CLASS:
| |||||||||||
318 | The cyclisation occurring through 4-amino radical of 2,4-diamino-butanoic acid: | ||
This subclass is indented under subclass 317. Peptides containing at least one diaminobutanoic acid residue
in the peptide cycle.
| |||
319 | Polymyxin; related peptides: | ||||||
This subclass is indented under subclass 318. Peptides containing at least half the amino acid residues
of the polypeptide produced by Bacillus polymyxa and possessing
antibiotic activity against Gram-negative bacteria.
| |||||||
320 | Bacitracin; related peptides: | ||||||
This subclass is indented under subclass 317. Peptides containing at least half the amino acid sequence
of Bacitracin.
| |||||||
321 | Containing only normal peptide links in the ring, i.e., homodetic cyclic peptides: |
| This subclass is indented under subclass 317. Cyclic peptides containing at least one ring formed by peptide bonds through only the alpha amino group of an amino acid. | |
322 | Peptides containing saccharide radicals, e.g., bieomycins, etc.: | ||||
This subclass is indented under subclass 300. Peptides containing at least one saccharide radical.
| |||||
323 | Peptides with at least one nonpeptide bond other than a disulfide bond joining two or more sequences of amino acid residues, e.g., homomeric heterodectic peptide of other than cyclic disulfide, depsipeptides, etc.: | ||||||
This subclass is indented under subclass 300. Peptides in which a peptide chain contains an interchain
nonpeptide moiety.
SEE OR SEARCH CLASS:
| |||||||
324 | 25 or more amino acid residues in defined sequence: | ||||
This subclass is indented under subclass 300. Compounds comprising from 25 or more amino acid residues
of defined primary structure.
| |||||
325 | 24 amino acid residues in defined sequence: | ||||
This subclass is indented under subclass 300. Compounds comprising 24 amino acid residues of defined primary
structures.
| |||||
326 | 15 to 23 amino acid residues in defined sequence: | ||||
This subclass is indented under subclass 300. Compounds comprising from 15 to 23 amino acid residues of
defined primary structure.
| |||||
327 | 11 to 14 amino acid residues in defined sequence: | ||||
This subclass is indented under subclass 300. Compounds comprising from 11 to 14 amino acid residues of
defined primary structure.
| |||||
328 | 8 to 10 amino acid residues in defined sequence: | ||||
This subclass is indented under subclass 300. Compounds comprising from 8 to 10 amino acid residues of
defined primary structure.
| |||||
329 | 6 to 7 amino acid residues in defined sequence: | ||||
This subclass is indented under subclass 300. Compounds comprising from 6 to 7 amino acid residues of
defined primary structure.
| |||||
330 | 4 to 5 amino acid residues in defined sequence: | ||||
This subclass is indented under subclass 300. Compounds comprising from 4 or 5 amino acid residues of
defined primary structure.
| |||||
331 | Tripeptides, e.g., tripeptide thyroliberin (TRH) melanostatin (MIF), etc.: | ||||
This subclass is indented under subclass 300. Compounds comprising 3 amino acid residues of defined primary
structure.
| |||||
332 | Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc.: | ||||
This subclass is indented under subclass 330. Subject matter, in which the amino acid residues are joined
by a peptide bond formed by other than an alpha amino acid.
SEE OR SEARCH THIS CLASS, SUBCLASS:
| |||||
333 | Synthesis of peptides: | ||||||
This subclass is indented under subclass 300. Processes which a polypeptide is synthesized (1) From amino
acids or protected amino acids or (2) by joining polypeptides or
protected polypeptides to amino acids or protected amino acids or
polypeptides or protected polypeptides.
SEE OR SEARCH CLASS:
| |||||||
334 | Polymer supported synthesis, e.g., solid phase synthesis, Merrifield synthesis, etc.: | ||||||
This subclass is indented under subclass 333. Processes in which synthesis includes the use of a soluble
or insoluble polymer or resin covalently attached to an amino acid
residue of the polypeptide chain being synthesized.
SEE OR SEARCH CLASS:
| |||||||
335 | Protecting or removing protective groups, e.g., carboxyl group protection, etc.: | ||||||||
This subclass is indented under subclass 333. Processes wherein a peptide group, whose purpose is to protect
a functional group in a peptide, is attached to or removed from
a peptide.
SEE OR SEARCH THIS CLASS, SUBCLASS:
| |||||||||
336 | Of side chain or sulfur containing group: | ||
This subclass is indented under subclass 335. Processes in which the addition or removal of the protective
groups is to or from a side or a sulfur containing group.
| |||
337 | Of amino group: | ||
This subclass is indented under subclass 335. Processes in which the addition or removal is of a protective
group that protects an amino group of the peptide.
| |||
338 | Solution phase synthesis: |
| This subclass is indented under subclass 333. Processes in which the synthesis takes place in solution. | |
339 | Segment condensation, e.g., Ugi condensation, etc.: | ||
This subclass is indented under subclass 338. Processes in which peptides of two or more amino acid residues
are joined with other peptide of two or more amino acid residues
to form a single large peptide.
| |||
340 | With phosphorus containing material: | ||
This subclass is indented under subclass 338. Processes in which phosphorus or a phosphorus containing
compound is present during synthesis.
| |||
341 | With use of carbonimide or imidazole: | ||
This subclass is indented under subclass 338. Processes in which an imidazole or a carbonimide is present
during synthesis.
| |||
342 | Mixed anhydride synthesis: |
| This subclass is indented under subclass 338. Processes in which the synthesis includes (1) forming a mixed anhydride by reacting an alpha-acylamino acid or an alpha-acylamino peptide with a lower alkyl chloroformate in the presence of a tertiary amino base, and then (2) reacting the resulting free amino group or a peptide derivative having a free amino group, to form a peptide. | |
343 | By hydrolysis: | ||
This subclass is indented under subclass 333. Processes in which the synthesis includes a step of hydrolysis.
| |||
344 | Separation or purification: | ||||||||||||||||||||||
This subclass is indented under subclass 300. Processes in which a pre-existing peptide is isolated from
a composition.
SEE OR SEARCH CLASS:
| |||||||||||||||||||||||
345 | Chemical aftertreatment, e.g., acylation, methylation, etc.: | ||
This subclass is indented under subclass 300. Processes in which a preexisting peptide is chemically modified.
| |||
350 | PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This subclass is indented under the class definition. Subject matter in which a polypeptide is composed of more
than 100 amino acid residues or has a molecular weight of greater
than 10,000.
SEE OR SEARCH CLASS:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
351 | Lymphokines, e.g., interferons, interlukins, etc.: | ||||||||
This subclass is indented under subclass 350. Proteins which are soluable immune mediators produced by
the cells of immune system.
SEE OR SEARCH CLASS:
| |||||||||
352 | Phosphoproteins, e.g., phosvitin, vitellogenin, etc.: | ||||||||||
This subclass is indented under subclass 350. Proteins which are conjugated proteins containing phosphate
esterified with the hydroxyl group of serine or threonine residues.
SEE OR SEARCH THIS CLASS, SUBCLASS:
| |||||||||||
353 | Scleroproteins, e.g., fibroin, elastin, silk, etc.: | ||
This subclass is indented under subclass 350. Proteins having the structure of scleroproteins and compounds
derived from these by addition to or deletion of parts of the polypeptide
structure.
| |||
354 | Gelatin: | ||||||||||||||
This subclass is indented under subclass 353. Proteins having the structure of gelatin and compounds derived
from these by addition to or deletion of parts of the polypeptide
structure.
SEE OR SEARCH CLASS:
| |||||||||||||||
355 | Separation, purification or synthesis: | ||||||
This subclass is indented under subclass 354. Processes in which gelatin is (a) isolated from a preexisting
material or composition of (b) is chemically synthesized.
SEE OR SEARCH CLASS:
| |||||||
356 | Collagen: | ||||||||||||||||||||||||||||||||||
This subclass is indented under subclass 353. Proteins having the structure of collagen and compounds
derived from these by addition to or deletion of parts of the polypeptide
structure.
SEE OR SEARCH CLASS:
| |||||||||||||||||||||||||||||||||||
357 | Keratin: | ||||||||||
This subclass is indented under subclass 350. Proteins having the structure of Keratin and compounds derived
from these by addition to or deletion of parts of the polypeptide
structure.
SEE OR SEARCH CLASS:
| |||||||||||
358 | Nucleoproteins, i.e., chromatin, chromosomal proteins, histones, protamines, salmine, etc.: | ||||||||
This subclass is indented under subclass 350. Proteins conjugated with nucleic acids.
| |||||||||
359 | Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc.: | ||||||||
This subclass is indented under subclass 350. Proteins which are conjugated with a lipid.
| |||||||||
360 | Casein or caseinate: | ||||||||||||||||
This subclass is indented under subclass 350. Proteins having the structure of casein and compounds derived
from these by addition to or deletion of parts of the polypeptide
structure.
SEE OR SEARCH CLASS:
| |||||||||||||||||
361 | Separation, purification or synthesis: | ||||||
This subclass is indented under subclass 360. Processes in which casein (1) is isolated from a preexisting
material or composition or (2) is chemically synthesized.
SEE OR SEARCH CLASS:
| |||||||
362 | Albumin: | ||||||||||
This subclass is indented under subclass 350. Proteins having the structure of albumin and compounds derived
from these by addition to or deletion of parts of the polypeptide
structure.
SEE OR SEARCH CLASS:
| |||||||||||
363 | Serum albumin, e.g., BSA, HSA etc.: | ||||||||||
This subclass is indented under subclass 362. Proteins having the structure of serum albumin and compounds
derived from these by addition to or deletion of parts of the polypeptide
structure.
SEE OR SEARCH CLASS:
| |||||||||||
364 | Separation, purification or synthesis: | ||||||
This subclass is indented under subclass 363. Processes in which serum albumins (a)
is isolated from a preexisting material or composition or (b) is
chemically synthesized.
SEE OR SEARCH CLASS:
| |||||||
365 | Lactalbumin, e.g., milk source, etc.: | ||||||||||||
This subclass is indented under subclass 362. Proteins having the structure of lactalbumin and compounds
derived from these by addition to or deletion of parts of the polypeptide
structure.
SEE OR SEARCH CLASS:
| |||||||||||||
366 | Separation, purification or synthesis: | ||||||
This subclass is indented under subclass 365. Processes in which lactal albumin (a)
is isolated from a preexisting material or composition or (b) is
chemically synthesized.
SEE OR SEARCH CLASS:
| |||||||
367 | Ovalalbumin, e.g., avidin, conalbumins, etc.: | ||||||||||||||||||
This subclass is indented under subclass 362. Proteins having the structure of ovalbumin and compounds
derived from these by addition to or deletion of parts of the polypeptiede
structure.
SEE OR SEARCH CLASS:
| |||||||||||||||||||
368 | Separation, purification or synthesis: | ||||||
This subclass is indented under subclass 367. Processes in which ovalbumins (a)
is isolated from a preexisting material or composition or (b) is
chemically synthesized.
SEE OR SEARCH CLASS:
| |||||||
369 | Separation, purification or synthesis: | ||||
This subclass is indented under subclass 362. Processes in which albumin (a) is isolated from a preexisting
material or composition or (b) is chemically synthesized.
SEE OR SEARCH CLASS:
| |||||
370 | Plant proteins, e.g., derived from legumes, algae or lichens, etc.: | ||||||||||||
This subclass is indented under subclass 350. Proteins derived from green or nongreen plants.
SEE OR SEARCH CLASS:
| |||||||||||||
371 | Derived from fungi, e.g., yeasts, mushroom, etc.: | ||||
| This subclass is indented under subclass 370. Plant proteins which are isolated or extracted from fungi
or from a fraction or isolate of fungi.
SEE OR SEARCH CLASS:
| |||||
372 | Derived from grain, e.g., prolamines, etc.: | ||||||||
This subclass is indented under subclass 370. Plant proteins which are isolated or extracted from grain
or from a fraction or isolate of grain.
SEE OR SEARCH CLASS:
| |||||||||
373 | Zein: | ||||||||
This subclass is indented under subclass 372. Proteins having the structure of zein and compounds derived
from these by addition to or deletion of parts of the polypeptide
structure.
SEE OR SEARCH CLASS:
| |||||||||
374 | Gluten or gliadin: | ||||||||
This subclass is indented under subclass 372. Proteins having the structure of Gluten or Gliadin and compounds
derived from these by addition or deletion of parts of the polypeptide structure.
SEE OR SEARCH CLASS:
| |||||||||
375 | Derived from wheat: | ||||
| This subclass is indented under subclass 372. Plant proteins which are isolated or extracted from wheat
or from a fraction or isolate of wheat.
SEE OR SEARCH CLASS:
| |||||
376 | Derived from corn: | ||
| This subclass is indented under subclass 372. Plant proteins which are isolated or extracted from corn
or from a fraction or isolate of corn.
SEE OR SEARCH CLASS:
| |||
377 | Derived from oil seed, e.g., cotton seed, rapeseed, sunflower, etc.: | ||||
This subclass is indented under subclass 370. Plant proteins which are isolated or extracted from oil
seed or from a fraction or isolate of oil seed.
SEE OR SEARCH CLASS:
| |||||
378 | Derived from soybean: | ||
| This subclass is indented under subclass 377. Plant proteins which are isolated or extracted from soybean
or from a fraction or isolate of soybean.
SEE OR SEARCH CLASS:
| |||
379 | Derived from leafy green plants, e.g., alfalfa pollen, etc.: | ||||||
This subclass is indented under subclass 370. Plant proteins which are isolated or extracted from leafy
green plants or from a fraction or isolate of leafy green plants.
SEE OR SEARCH CLASS:
| |||||||
380 | Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc.: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This subclass is indented under subclass 350. Proteins identified as Blood Proteins or Globulins and compounds
derived from these by addition to or deletion of parts of the polypeptide
structure.
SEE OR SEARCH CLASS:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
381 | Blood coagulation factors and fibrin, e.g., thromboplastin, etc.: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This subclass is indented under subclass 380. Proteins identified as Blood Coagulation Factors or fibrin
and compounds derived from these by addition to or deletion of parts
of polypeptide structure.
SEE OR SEARCH CLASS:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
382 | Fibrin or fibrin intermediates, e.g., fibrinogen etc.: | ||||||||||
This subclass is indented under subclass 381. Proteins having the structure of fibrin and compounds derived
for these by addition to or deletion of parts of the polypeptide
structure.
SEE OR SEARCH CLASS:
| |||||||||||
383 | Blood coagulation factor VIII, AHF: | ||||||||||||
This subclass is indented under subclass 381. Proteins having the structure of and compounds derived from
these by addition to or deletion of parts of the polypeptide structure.
SEE OR SEARCH CLASS:
| |||||||||||||
384 | Blood coagulation FACTOR II, or factor II + VII + IX +, i.e., prothrombin or prothrombin complex or factor: | ||||||||||||||
This subclass is indented under subclass 381. Proteins having the structure of factor II and or prothrombin
complex and compounds derived from these by addition to or deletion
of parts of the polypeptide structure.
SEE OR SEARCH CLASS:
| |||||||||||||||
385 | Hemoglobins or globins: | ||||||||||||||
This subclass is indented under subclass 380. Proteins having the structure of hemoglobins or globins
and compounds derived from these by addition to or deletion of parts
of the polypeptide structure.
SEE OR SEARCH THIS CLASS, SUBCLASS:
SEE OR SEARCH CLASS:
| |||||||||||||||
386 | Globulins: | ||||||||
This subclass is indented under subclass 380. Proteins identified as globulins and compounds derived from
these by addition to or deletion of parts of the polypeptide structure.
| |||||||||
387.1 | Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin, antibody, or fragment thereof that is conjugated or adsorbed: | ||||||||||||||||||||||||||||||||||||||
This subclass is indented under subclass 386. Subject matter in which the protein has the structure of
an immunoglobulin, antibody, or fragment thereof that is not conjugated
or adsorbed to another substance.
SEE OR SEARCH THIS CLASS, SUBCLASS:
SEE OR SEARCH CLASS:
| |||||||||||||||||||||||||||||||||||||||
387.2 | Anti-idiotypic: | ||||||||
This subclass is indented under subclass 387.1. Subject matter involving an antibody or antibody fragment
that binds another antibody at one of its idiotopes.
| |||||||||
387.3 | Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobulin fusion protein, etc.): | ||||||
This subclass is indented under subclass 387.1. Subject matter involving an antibody or antibody fragment
altered with respect to its amino acid sequence; with respect to
its composition of heavy and light chains or immunoglobulin domains;
or with respect to its glycosylation, as compared with that found
in nature; or involving an antibody or antibody fragment fused to
a nonimmunoglobulin amino acid sequence.
| |||||||
387.5 | Binds oligosaccharide structure: | ||||||
This subclass is indented under subclass 387.1. Subject matter involving an antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
an oligosaccharide structure that is either free, a component of
a glycoprotein, or a component of a glycolipid.
| |||||||
387.7 | Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.): | ||
This subclass is indented under subclass 387.1. Subject matter involving an antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
an expression product or fragment thereof of a cancer-related gene,
such as an oncogene or proto-oncogene.
| |||
387.9 | Binds specifically-identified amino acid sequence: | ||
This subclass is indented under subclass 387.1. Subject matter involving an antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
a protein or peptide antigen or antigenic determinant whose amino
acid sequence is disclosed.
| |||
388.1 | Monoclonal: | ||||||||||
This subclass is indented under subclass 387.1. Subject matter involving an antibody or fragment thereof
produced by a clone of cells or cell line that is derived from a
single antibody-producing cell, wherein said antibody is identical
to all other antibodies produced by that clone of cells or cell
line.
SEE OR SEARCH THIS CLASS, SUBCLASS:
SEE OR SEARCH CLASS:
| |||||||||||
388.15 | Human: |
| This subclass is indented under subclass 388.1. Subject matter involving a monoclonal antibody or fragment thereof derived from a human source, or whose amino acid sequence is identical to that found in humans. | |
388.2 | Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.): | ||||||
This subclass is indented under subclass 388.1. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
an integral or isolated part of a micro-organism, or with a substance
shed or secreted by a micro-organism, or with a chemically-altered
component of a microorganism, or with a chemically-altered substance
shed or secreted by a micro-organism.
| |||||||
388.21 | Binds nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.): | ||
This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
a nucleic acid; a component of a nucleic acid, such as a nucleotide
or nucleoside; or a modified nucleic acid, such as carcinogen-DNA
adduct resulting from exposure to a carcinogen.
| |||
388.22 | Binds receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.): | ||||
This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
a free or micro-organism-associated receptor.
| |||||
388.23 | Binds lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.): | ||||||||||
This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
a lymphokine, cytokine, or any other secreted growth stimulatory
factor, growth inhibitory factor, differentiation factor, or intercellular
mediator that targets any type(s) of hematopoietic cells.
| |||||||||||
388.24 | Binds hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, Mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.): | ||||||
This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
a neurotransmitter, with a hormone, or with any other secreted growth
regulatory factor, differentiation factor, or intercellular mediator
that targets cells other than hematopoietic cells.
| |||||||
388.25 | Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.): | ||||||
This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
a plasma protein, serum protein, or with fibrin.
| |||||||
388.26 | Binds enzyme: |
| This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an enzyme. | |
388.3 | Binds virus or component or product thereof (e.g., virus-associated antigen, etc.): |
| This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a virus, or with a substance shed by a virus, such as a viral antigen. | |
388.35 | Binds retrovirus or component or product thereof (e.g., HIV, LAV, HTLV, etc.): | ||
This subclass is indented under subclass 388.3. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
an integral or isolated part of a retrovirus, or with a substance
shed by a retrovirus, such as a viral antigen.
| |||
388.4 | Binds bacterium or similar microorganism or component or product thereof (e.g., Streptococcus, Legionella, Mycoplasma, bacterium-associated antigen, exotoxin, etc.): | ||
This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
an integral or isolated part of a bacterium or similar micro-organism,
or with a substance shed or secreted by a bacterium or similar micro-organism.
| |||
388.5 | Binds fungus or plant cell or component or product thereof (e.g., fungus-associated antigen, etc.): | ||
This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
an integral or isolated part of a fungus or plant cell, or with
a substance shed or secreted by a fungus or plant cell.
| |||
388.6 | Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell-surface antigen, etc.): | ||
This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
an integral or isolated part of a parasitic protozoan or metazoan
cell, or with a substance shed or secreted by a parasitic protozoan
or metazoan cell.
| |||
388.7 | Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.): | ||
This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
an integral or isolated part of a hematopoietic cell, or with a
substance shed or secreted by a hematopoietic cell.
| |||
388.73 | Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage acute lymphoblastic leukemia cell, B-lymphocytic cell-surface antigen, etc.): | ||
This subclass is indented under subclass 388.7. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
an integral or isolated part of a lymphocytic or lymphocytic-like
cell, or with a substance shed or secreted by a lymphocytic cell or
lymphocytic-like cell.
| |||
388.75 | Binds T-lymphocytic cell or component or product thereof (e.g., T cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic cell-surface antigen, etc.): |
| This subclass is indented under subclass 388.73. Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a T-lymphocytic cell, or with a substance shed or secreted by a T-lymphocytic cell. | |
388.8 | Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.): |
| This subclass is indented under subclass 388.2. Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a cancer cell, or with a substance shed or secreted by a cancer cell. | |
388.85 | Binds antigen characterized by name or molecular weight (e.g., CEA, NCA, CC glycoprotein, melanoma gp 150 antigen, etc.): |
| This subclass is indented under subclass 388.8. Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an antigen that is an integral or isolated part of a cancer cell, or that is shed or secreted by a cancer cell, and that is disclosed by name or molecular weight. | |
388.9 | Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.): | ||
This subclass is indented under subclass 388.1. Subject matter involving a monoclonal antibody or antigen-binding
fragment thereof whose antigen-binding site(s) will combine with
a drug, hapten, hapten-carrier complex, or with a specifically-identified
chemical structure that is disclosed.
| |||
389.1 | Polyclonal antibody or immunoglobulin of identified binding specificity: | ||
This subclass is indented under subclass 387.1. Subject matter involving a polyclonal antibody or
immunoglobulin or antigen-binding fragment thereof whose binding
specificity is disclosed.
| |||
389.2 | Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.): | ||||||||||||
This subclass is indented under subclass 389.1. Subject matter involving a polyclonal antibody or immunoglobulin
or antigen-binding fragment thereof whose antigen-binding
site(s) will combine with a hormone, lymphokine, cytokine, or other
secreted growth regulatory factor, differentiation factor, intercellular mediator,
or neurotransmitter.
| |||||||||||||
389.3 | Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.): | ||||||
This subclass is indented under subclass 389.1. Subject matter involving a polyclonal antibody or immunoglobulin
or antigen-binding fragment thereof whose antigen-binding
site(s) will combine with a plasma protein, serum protein, or with
fibrin.
| |||||||
389.4 | Binds virus or component or product thereof (e.g., virus-associated antigen, etc.): |
| This subclass is indented under subclass 389.1. Subject matter involving a polyclonal antibody or immunoglobulin or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a virus, or with a substance shed by a virus, such as a viral antigen. | |
389.5 | Binds bacterium or similar microorganism or component or product thereof (e.g., Pseudomonas, Chlamydia, Clostridium, bacterium-associated antigen, etc.): | ||
This subclass is indented under subclass 389.1. Subject matter involving a polyclonal antibody or
immunoglobulin or antigen-binding fragment thereof whose antigen-binding site(s)
will combine with an integral or isolated part of a bacterium or
similar micro-organism, or with a substance shed or secreted by
a bacterium or similar micro-organism.
| |||
389.6 | Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, bone marrow cell, lymphocyte, leukemic cell, hematopoietic cell-surface antigen, hemoglobin, etc.): | ||
This subclass is indented under subclass 389.1. Subject matter involving a polyclonal antibody or immunoglobulin
or antigen-binding fragment thereof whose antigen-binding site(s) will
combine with an integral or isolated part of a hematopoietic cell,
or with a substance shed or secreted by a hematopoietic cell.
| |||
389.7 | Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.): |
| This subclass is indented under subclass 389.1. Subject matter involving a polyclonal antibody or immunoglobulin or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a cancer cell, or with a substance shed or secreted by a cancer cell. | |
389.8 | Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.): | ||
This subclass is indented under subclass 389.1. Subject matter involving a polyclonal antibody or immunoglobulin
or antigen-binding fragment thereof whose antigen-binding site(s)
will combine with a drug, hapten, hapten-carrier complex, or with
a specifically-identified chemical structure that is disclosed.
| |||
390.1 | Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.): | ||
| This subclass is indented under subclass 387.1. Subject matter involving a process of removing or inactivating
a virus, a bacterium, or a component or product thereof that contaminates
an immunoglobulin preparation; or an immunoglobulin preparation
prepared thereby.
SEE OR SEARCH THIS CLASS, SUBCLASS:
| |||
390.5 | Removing, dissociating or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.): | ||||
This subclass is indented under subclass 387.1. Subject matter involving a process of removing, dissociating,
or preventing the formation of aggregated, denatured, fragmented,
polymerized immunoglobulins or antibodies; or a process of preventing
or reducing complement fixation or complement binding by an immunoglobulin
preparation; or a process of reducing the antigenicity of an immunoglobulin
preparation; or a process of removing, inactivating, or inhibiting
plasma proteins, such as proteolytic enzymes, that contaminate an
immunoglobulin preparation; or involving an immunoglobulin preparation
prepared thereby.
SEE OR SEARCH THIS CLASS, SUBCLASS:
| |||||
391.1 | Monoclonal or polyclonal antibody or immunoglobulin or fragment thereof that is conjugated or adsorbed (e.g., adsorbed to a solid support, etc.): | ||||
This subclass is indented under subclass 386. Subject matter involving a monoclonal or polyclonal antibody
or immunoglobulin or fragment thereof that is bound to another molecule via
a covalent bond or chemical group, or that is adsorbed to another
substance.
SEE OR SEARCH CLASS:
| |||||
391.3 | Conjugated to a detectable label or radioisotope or radionuclide or heavy metal-containing compound: | ||
| This subclass is indented under subclass 391.1. Subject matter involving a monoclonal or polyclonal antibody
or immunoglobulin or fragment thereof that is conjugated to a detectable label,
radioisotope or radionuclide, or heavy metal-containing compound.
SEE OR SEARCH CLASS:
|